AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

AstraZeneca opened a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...

The facility is part of AstraZeneca's $3.5 billion investment in U.S. research and manufacturing. As he launches a North ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

A pharmaceutical giant has opened a new Rockville manufacturing hub, a whopping $300 million investment — and a boost for ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...